Schizoaffective Disorder
📧 Sign up to get email alerts when something new happens for Schizoaffective Disorder.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2020-07-29FDA Approved: VERSACLOZ — Supplemental Application (TruPharma LLC)
FDA approved a supplemental application for Versacloz (clozapine) submitted by TruPharma LLC.
-
FDA approval · 2020-07-26FDA Approved: CLOZAPINE — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental ANDA for Clozapine from Mylan Pharmaceuticals, approving a generic version of Clozapine under ANDA 201824.
-
CLINICAL_TRIALS trial_result · 2020-07-16Clinical Trial Update: A Trial to Explore Acceptance and Performance of Using a Digital Medicine System With Healthcare Professionals and Adults With Schizophrenia, Schizoaffective Disorder, or First Episode Psychosis on an Oral Atypical Antipsychotic [Phase 4]
Phase 4 trial evaluating acceptance and performance of a digital medicine system for adults with schizophrenia, schizoaffective disorder, or…
-
CLINICAL_TRIALS trial_result · 2020-05-26Clinical Trial Update: Estradiol as add-on to Antipsychotics [Phase 3]
Phase 3 clinical trial update investigating estradiol as an add-on treatment to antipsychotics for schizophrenia-spectrum disorders.
-
CLINICAL_TRIALS trial_result · 2020-05-22Clinical Trial Update: Estradiol Patch as add-on to Antipsychotics in Patients With Schizophrenia, Schizoaffective or Schizophreniform Disorder [Phase 3]
A Phase 3 clinical trial evaluated estradiol patch as an add-on to antipsychotics for schizophrenia and related disorders; the study has com…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2020-04-20Clinical Trial Update: Antipsychotic Effects on Brain Function in Schizophrenia [Phase 4]
Phase 4 trial update on antipsychotic effects on brain function in schizophrenia and related disorders; study terminated with posted results…
-
CLINICAL_TRIALS trial_result · 2020-04-13Clinical Trial Update: Adapted Cognitive/Affective Remediation for Cannabis Misuse in Schizophrenia [Phase 1, Phase 2]
A Phase 1/2 clinical trial investigating adapted cognitive/affective remediation for cannabis misuse in individuals with schizophrenia or sc…
-
CLINICAL_TRIALS trial_result · 2020-04-08Clinical Trial Update: Naltrexone for Antipsychotic-Induced Weight Gain [NA]
Clinical trial update for naltrexone addressing antipsychotic-induced weight gain; study completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-02-19Clinical Trial Update: Study in Stabilized Schizophrenic Patients to Evaluate the Pharmacokinetics of Risperidone and 9-Hydroxy (OH)-Risperidone When Risperidone is Administered From a Polyurethane Implant [Phase 2]
Phase 2 trial assessing pharmacokinetics of risperidone and 9-hydroxy risperidone from a polyurethane implant in stabilized schizophrenic pa…
-
CLINICAL_TRIALS trial_result · 2020-01-09Clinical Trial Update: Selective Estrogen Receptor Modulators for Women of Child-bearing Age With Schizophrenia [Phase 4]
Phase 4 trial update evaluating selective estrogen receptor modulators for women of child-bearing age with schizophrenia or schizoaffective …
-
CLINICAL_TRIALS trial_result · 2019-11-25Clinical Trial Update: Theta Burst Stimulation for Schizophrenia [NA]
A completed clinical trial evaluating theta burst stimulation for schizophrenia and schizoaffective disorder; results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-10-02Clinical Trial Update: Glucose and Lipid Metabolism on Antipsychotic Medication [NA]
Clinical trial completed studying glucose and lipid metabolism effects of antipsychotic medication in schizophrenia-related conditions; resu…
-
CLINICAL_TRIALS trial_result · 2019-08-20Clinical Trial Update: Adjunctive Treatment for Decreasing Symptoms of Schizophrenia [Phase 2, Phase 3]
Phase 2/3 clinical trial evaluating adjunctive treatment to reduce schizophrenia symptoms; study completed.
-
CLINICAL_TRIALS research · 2019-08-06Clinical Trial Update: Anticonvulsant Mood Stabilizers, Antipsychotic Drugs and the Insulin Resistance Syndrome [NA]
Clinical trial update related to anticonvulsants, mood stabilizers, and antipsychotics in relation to insulin resistance, with completed sta…
-
CLINICAL_TRIALS trial_result · 2019-07-15Clinical Trial Update: PTSD (PostTraumatic Stress Disorder) Services for Veterans With SMI (Severe Mental Illness) [NA]
Completed clinical trial studying PTSD services for veterans with severe mental illness; results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-06-24Clinical Trial Update: Prednisolone Addition for Patients With Recent-onset Psychotic Disorder [Phase 4]
Phase 4 trial update on adding prednisolone for patients with recent-onset psychotic disorder; study terminated.
-
CLINICAL_TRIALS trial_result · 2019-06-21Clinical Trial Update: A New Paradigm for Illness Monitoring and Relapse Prevention in Schizophrenia [NA]
Clinical trial update on a new paradigm for illness monitoring and relapse prevention in schizophrenia and schizoaffective disorder; study c…
-
CLINICAL_TRIALS trial_result · 2019-06-07Clinical Trial Update: Comparative Effectiveness of Adaptive Treatment Strategies for Schizophrenia
ClinicalTrials.gov reports the completed trial comparing adaptive treatment strategies for schizophrenia and schizoaffective disorder. Resul…
-
CLINICAL_TRIALS trial_result · 2019-05-15Clinical Trial Update: Effects of Risperdal Consta on Ability to Benefit From Social Skills Training in Schizophrenia [Phase 3]
Phase 3 clinical trial evaluating the impact of Risperdal Consta on the benefit of social skills training in patients with schizophrenia or …
-
CLINICAL_TRIALS trial_result · 2019-05-13Clinical Trial Update: Development of a Mobile System for Self-management of Schizophrenia (SOS) [NA]
A completed clinical trial evaluating a mobile self-management system for schizophrenia and schizoaffective disorder; results posted in 2019…
-
CLINICAL_TRIALS trial_result · 2019-05-08Clinical Trial Update: The Effect of N-Acetyl Cysteine on Cortical Erosion in Early Stage Schizophrenia [Phase 4]
Phase 4 trial assessing the effect of N-acetylcysteine on cortical erosion in early-stage schizophrenia; study completed with results posted…
-
CLINICAL_TRIALS trial_result · 2019-05-07Clinical Trial Update: Nicotinic Receptors and Schizophrenia [Phase 2]
Phase 2 clinical trial update on nicotinic receptor-targeted approach for schizophrenia and schizoaffective disorder; results posted after c…
-
CLINICAL_TRIALS trial_result · 2019-04-16Clinical Trial Update: Comparison of Antipsychotic Combination Treatment of Olanzapine and Amisulpride to Monotherapy [Phase 4]
Phase 4 trial comparing the combination of olanzapine and amisulpride to monotherapy in schizophrenia and schizoaffective disorder has compl…
-
CLINICAL_TRIALS trial_result · 2019-04-08Clinical Trial Update: Nicotinic Enhancement of Cognitive Remediation Training in Schizophrenia [NA]
This completed clinical trial evaluated nicotinic enhancement of cognitive remediation training in schizophrenia and schizoaffective disorde…
-
CLINICAL_TRIALS trial_result · 2019-03-26Clinical Trial Update: Pentosan Polysulfate Sodium and Meclofenamic Acid as Treatments in Patients With Psychotic Disorders [Phase 2]
Phase 2 trial evaluating pentosan polysulfate sodium and meclofenamic acid for psychotic disorders, completed with posted results.